English (United Kingdom)Deutsch (DE-CH-AT)
PED MIND CALL
+49-151-41936762
Topical timololmaleat-gel in the treatment of pediatric hemangioma
The study was initiated in 12/2010 by discussion of a publication published by a group of "toronto sick children", who published the first cases/results of topical beta-blocking drug in pediatric hemangioma.
Hämagiom
Contact person and development of study protokoll is Mrs. Weissenstein.
 

Director of Ped Mind Institute
Stefan Bittmann, M.D., M.A.
Weissenstein A, Villalon G, Luchter E, Bittmann S:
“Pipeline bandage with marigold essence in pediatric bee sting lesions”
Applied Medical Research 1 (1):32-34, 2015
» publication download

Weissenstein A, Villalon G, Luchter E, Bittmann S:
Tumor suppressor candidate 3 gene (TUSC 3) deletion correlates with mental retardation in a child”
Applied Medical Research 1 (1): 35-36, 2015
» publication download

Weissenstein A, Villalon G, Luchter E, Bittmann S:
“A newborn with a missing cerebrum”
Applied Medical Research (1):37-38, 2015
» publication download

Weissenstein A, Luchter E, Bittmann S
"Successful treatment of infantile haemangioma with propranolol"
accepted for publication, British Journal of Nursing 02/2015
» publication download

Weissenstein A, Luchter E, Bittmann S:
"Alice in Wonderland Syndrome: a rare neurological manifestation with microscopy in a 6 years old child"
accepted for publication in: Journal of Pediatric Neurosciences 12/2014
» publication download

Weissenstein A, Villalon G, Luchter E, Bittmann:
"Vaccine patches in pediatrics: future or false hope?"
International Journal of Innovative Medicine and Health Sciences (UK), Vol.2, 6-10, 2014
» publication download